Garmin Epix Pro Gen 2: AMOLED Endurance Watch With FDA Cleared ECG and Advanced Navigation

Garmin’s premium AMOLED multisport watch pairs FDA cleared atrial fibrillation screening with deep training analytics, multi band GPS, and expedition grade durability in a display that finally matches the data it delivers.

Presented By Our Partners

Atrial fibrillation does not announce itself with chest pain or shortness of breath in many cases. For millions of people, it flickers in and out of the heart’s electrical rhythm during sleep, during periods of high stress, or after intense exercise, producing no symptoms at all until it triggers a stroke. The American Heart Association estimates that at least 2.7 million Americans are living with atrial fibrillation, and a significant portion remain undiagnosed. The condition increases stroke risk by approximately five fold, and its prevalence climbs steeply with age: roughly 9% of adults over 65 carry the diagnosis, with an unknown additional percentage living with undetected paroxysmal episodes.

The clinical challenge is timing. A standard 12 lead ECG in a cardiologist’s office captures a 10 second snapshot of cardiac electrical activity. If the arrhythmia is not happening during those 10 seconds, the test returns normal. Even 24 to 48 hour Holter monitors miss intermittent episodes that may occur only a few times per week. The diagnostic question is not whether the technology to detect AF exists. It is whether the monitoring window is long enough to catch it.

Consumer wearables are rewriting this equation. A device worn continuously, day and night, that can record an ECG on demand when it detects an irregular rhythm offers a monitoring window measured in weeks and months rather than seconds and hours. The Garmin Epix Pro Gen 2 is one of the most complete expressions of this approach: an AMOLED display endurance watch with FDA cleared ECG for atrial fibrillation detection, layered onto Garmin’s industry leading training analytics, multi band GPS navigation, and expedition grade construction.

What Is the Garmin Epix Pro Gen 2?

The Garmin Epix Pro Gen 2 is Garmin’s premium multisport smartwatch, combining the training analytics engine of the Fenix series with a vibrant AMOLED touchscreen display. Available in 42mm, 47mm, and 51mm case sizes, it offers the same core sensor suite and software platform as the Fenix 7X Pro but replaces the memory in pixel display with an AMOLED screen that delivers richer color, higher contrast, and better readability for data dense training screens and map navigation.

The sensor array includes Garmin’s Elevate v5 optical heart rate monitor for continuous HR, HRV, and SpO2 tracking, plus an electrical sensor for on demand ECG recording. The ECG function is FDA cleared for detecting atrial fibrillation and classifying normal sinus rhythm. Additional health and training features include VO2 max estimation (via Firstbeat Analytics algorithms), Training Readiness scoring, Training Status and Training Load analysis, Body Battery energy monitoring, HRV Status with rolling seven day and three month baselines, and sleep staging with detailed sleep score.

Performance features include multi band GPS (GPS, GLONASS, Galileo), ClimbPro ascent planning, Hill Score for evaluating climbing ability, wrist based running power, and preloaded topographic maps with turn by turn navigation. A built in LED flashlight with variable brightness and safety strobe mode extends utility for early morning and night running. The watch retails at $999.99 with no subscription fee for any feature.

The Science Behind It: Atrial Fibrillation Detection and Autonomic Health

The Epix Pro Gen 2 carries two distinct clinical value propositions: screening for atrial fibrillation through its FDA cleared ECG and tracking autonomic nervous system health through continuous HRV monitoring. Both connect directly to cardiovascular disease, the first of the Four Villains that Healthcare Discovery‘s longevity framework identifies as the primary threats to human healthspan.

Atrial fibrillation is the most common sustained cardiac arrhythmia, and its significance extends far beyond an irregular heartbeat. AF disrupts the atrium’s ability to contract effectively, allowing blood to pool and form clots that can travel to the brain and cause stroke. The BASEL Wearable Study, published in 2023 in JACC: Clinical Electrophysiology by Mannhart et al., evaluated consumer smartwatch ECG recordings across 201 hospitalized patients using five different wrist worn devices. The study found that consumer grade single lead ECG recordings achieved high diagnostic accuracy for atrial fibrillation, with sensitivity exceeding 90% across multiple devices tested.

Earlier validation research reinforced these findings. According to PubMed, a 2019 study published in Circulation: Arrhythmia and Electrophysiology by Wasserlauf et al. evaluated the Apple Watch’s ECG algorithm against 12 lead ECG and found 97.5% sensitivity for AF detection in a cohort of cardiac rhythm monitoring patients. While that study focused on Apple hardware, the underlying single lead ECG methodology is technically comparable across consumer devices using similar electrical sensor architectures.

Heart rate variability provides the second clinical dimension. HRV reflects the balance between sympathetic (“fight or flight”) and parasympathetic (“rest and digest”) nervous system activity. According to the European Society of Cardiology’s foundational 1996 guidelines published in Circulation, reduced HRV is independently associated with increased risk of sudden cardiac death, heart failure progression, and all cause mortality. The Epix Pro Gen 2 tracks HRV continuously during sleep and generates a rolling seven day average compared against a personal three month baseline, allowing users to observe their autonomic health trajectory over time.

A 2023 review published in Trends in Cardiovascular Medicine by Strik et al. examined the clinical potential of smartwatch ECG recordings beyond arrhythmia detection, identifying emerging applications in QT interval monitoring, ischemia detection, and hyperkalemia screening. While these applications remain investigational, they signal the expanding clinical horizon for the single lead ECG data that devices like the Epix Pro Gen 2 already capture.

That is the science. Here is how the Garmin Epix Pro Gen 2 applies it.

What the Garmin Epix Pro Gen 2 Does Well

The Epix Pro Gen 2’s defining advantage is that it delivers the full Garmin training and health ecosystem on a display that does justice to the data. The AMOLED screen transforms complex data visualizations, training zone indicators, map navigation, and recovery metrics into information that is immediately readable in any lighting condition. For a platform as data rich as Garmin Connect, display quality is not cosmetic. It directly impacts whether users engage with the information that informs better health decisions.

The FDA cleared ECG adds a clinical screening layer that the AMOLED only Forerunner 965 lacks. Users can record a 30 second single lead ECG on demand by resting two fingers on the watch’s rear sensor. The algorithm classifies results as normal sinus rhythm, atrial fibrillation, or inconclusive, and stores readings in Garmin Connect for export and physician review. For active adults over 50 who want continuous wear AF screening integrated into their training device, the Epix Pro Gen 2 is the most complete option in Garmin’s lineup.

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

Training analytics match the Fenix 7X Pro in depth and exceed it in presentation. Training Readiness, Training Status, Body Battery, HRV Status, and VO2 max tracking all function identically to the Fenix platform, but the AMOLED display renders multi metric dashboards, trend graphs, and color coded zones with clarity that the Fenix’s MIP display cannot match. For data driven athletes who review their metrics daily, this difference compounds over time.

The multi size options (42mm, 47mm, 51mm) address one of the Fenix 7X Pro’s most common complaints: the 51mm case is too large for many wrists, especially during sleep. The Epix Pro Gen 2’s 42mm and 47mm options offer the full feature set in a more wearable package, improving sleep tracking data quality by encouraging overnight wear.

Pricing, Access, and Practical Realities

The Garmin Epix Pro Gen 2 retails at $999.99 for the sapphire edition (all sizes). Standard crystal editions are available at lower price points. No subscription is required for any feature. Garmin Connect, which provides all analytics, data visualization, and export functionality, is entirely free. First year total cost of ownership is $999.99, with zero recurring costs.

The watch is compatible with both iOS and Android smartphones via the Garmin Connect app. All features, including ECG, function identically on both platforms, a significant advantage over Samsung (which restricts ECG to Galaxy phones) and a parity feature with Apple (which restricts to iPhone).

Regarding regulatory status: the ECG feature is FDA cleared for detecting atrial fibrillation and classifying normal sinus rhythm. It records a single lead ECG and cannot detect all arrhythmias, conduction abnormalities, or structural heart conditions. The VO2 max estimation, HRV tracking, SpO2, and all training analytics features are classified as general wellness tools without FDA clearance.

HSA/FSA eligibility is possible with a Letter of Medical Necessity from a healthcare provider, particularly when prescribed for cardiac monitoring. Approval varies by plan administrator.

Who the Garmin Epix Pro Gen 2 Is Best For

The Epix Pro Gen 2 is ideal for endurance athletes and active adults who want the full Garmin training platform with an AMOLED display and FDA cleared ECG. It is particularly well suited for athletes over 40 who want integrated AF screening without carrying a separate cardiac monitor, trail runners and mountaineers who rely on map readability in variable lighting conditions, and triathletes who want multi sport analytics with the best display in Garmin’s lineup.

It also serves health conscious professionals who want a premium daily wear watch that doubles as a clinical screening tool. The 42mm and 47mm options are refined enough for business settings while still delivering expedition grade durability and the full training feature set.

Who may want to skip it: budget conscious runners who do not need ECG should consider the Garmin Forerunner 965 ($599.99), which shares the same training analytics engine and AMOLED display at $400 less. Users who prioritize extreme battery life and solar charging over display quality should choose the Fenix 7X Pro. Anyone who does not use multi sport training profiles, map navigation, or advanced training analytics will find the $999.99 price excessive when simpler devices like the Garmin Venu 3 ($449.99) cover basic health monitoring adequately.

How It Compares

Against the Garmin Fenix 7X Pro Sapphire Solar ($999.99), the Epix Pro Gen 2 offers a dramatically better AMOLED display and multiple size options (42mm, 47mm, 51mm vs. Fenix’s 51mm only). The Fenix counters with solar charging that extends battery life to 37 days (vs. Epix Pro’s 16 days for the 47mm in smartwatch mode) and a titanium bezel construction. Both watches share the same ECG, training analytics, and sensor suite. The choice comes down to display preference versus battery endurance.

Compared to the Apple Watch Ultra 2 ($799), the Epix Pro Gen 2 offers far longer battery life (16 days vs. 36 hours), more sophisticated training analytics, and cross platform smartphone compatibility. Apple provides cellular connectivity, a larger app ecosystem, crash detection, and a more intuitive user interface for non athletes. For serious endurance athletes, the Epix Pro Gen 2 is the stronger training tool. For general consumers who exercise regularly, Apple offers a more versatile daily wear experience.

Against the Samsung Galaxy Watch Ultra ($649.99), the Epix Pro Gen 2 costs $350 more but delivers deeper training analytics, longer battery life, and full iOS compatibility. Samsung offers FDA cleared sleep apnea detection that Garmin lacks and a lower entry price. For clinical cardiovascular screening breadth, Samsung wins. For training analytics depth, Garmin wins.

Limitations and Open Questions

Battery life is the Epix Pro Gen 2’s most notable trade off against the Fenix lineup. The AMOLED display consumes significantly more power than a MIP display, reducing smartwatch battery life from the Fenix’s 37 days (with solar) to approximately 16 days for the 47mm Epix Pro. In GPS mode, the difference is more pronounced: approximately 42 hours (Epix Pro 47mm) versus 122 hours (Fenix 7X Pro with solar). For multi day expeditions without charging access, this gap matters.

At $999.99, the Epix Pro Gen 2 is one of the most expensive consumer wearables available. Users must evaluate whether the AMOLED display upgrade over the Fenix 7X Pro (same price, same features, different display technology) justifies the battery life trade off, or whether the ECG upgrade over the Forerunner 965 ($599.99, same AMOLED display, no ECG) justifies the $400 premium.

The ECG feature, while FDA cleared, requires on demand initiation. The watch does not continuously monitor for atrial fibrillation the way Apple Watch’s passive irregular rhythm notification system does. Users must actively choose to record an ECG, which means asymptomatic episodes occurring between recordings may be missed. Garmin has not published device specific peer reviewed validation data for its ECG algorithm, though the single lead methodology is well validated across the broader clinical literature.

Garmin’s software ecosystem, while powerful, has a steeper learning curve than Apple or Fitbit. New users may find the depth of metrics and settings overwhelming without prior experience with Garmin devices or structured training concepts.

What This Means for Your Health

The Garmin Epix Pro Gen 2 sits at the intersection of two foundational health strategies. The first is Movement, the third of HealthcareDiscovery.ai’s Five Pillars: structured exercise, tracked and optimized through the most advanced training analytics available on any consumer wearable. The second is cardiovascular screening, a direct defense against the first of the Four Villains, through FDA cleared ECG monitoring that extends the detection window for the arrhythmia most commonly responsible for stroke.

These two functions are not separate products sharing a case. They are complementary layers of the same health strategy. Consistent exercise improves VO2 max, reduces resting heart rate, increases HRV, and directly lowers cardiovascular mortality risk. ECG screening monitors for the arrhythmia that can undermine those benefits silently. Training analytics ensure that exercise stress is balanced against recovery, preventing the overtraining that can paradoxically increase cardiac risk in otherwise healthy athletes.

The longevity escape velocity framework asks a simple question: can you maintain your health long enough to benefit from the exponential medical breakthroughs arriving in the coming decade? The Epix Pro Gen 2 addresses this question from both directions. It helps you build cardiovascular fitness that extends healthspan through daily training guidance. And it screens for the cardiac condition most likely to interrupt that trajectory without warning.

The technology is the bridge. The fundamentals are the foundation. Seven to nine hours of sleep, whole food nutrition, consistent resistance and aerobic training, breathwork for stress regulation, and purposeful engagement with life. When the fundamentals are in place, a device like the Epix Pro Gen 2 becomes what consumer health technology should be: not a replacement for medical care, but an early warning system that connects your daily choices to your long term health trajectory.

Explore the full wearable guide

See how the Garmin Epix Pro Gen 2 compares with smart rings, watches, ECG devices, and other connected health hardware across the full Healthcare Discovery wearables guide.

Frequently Asked Questions

Does the Garmin Epix Pro Gen 2 have ECG?
Yes. The Epix Pro Gen 2 includes an FDA cleared ECG function that detects atrial fibrillation and classifies normal sinus rhythm. Users record a 30 second single lead ECG by placing two fingers on the rear sensor. Results are stored in Garmin Connect and exportable as PDFs for physician review. The feature is available in the United States and select international markets.

What is the difference between the Garmin Epix Pro Gen 2 and the Fenix 7X Pro?
Both watches share the same sensor suite, ECG capability, training analytics, and software platform. The primary differences are display technology (Epix Pro uses AMOLED; Fenix uses memory in pixel), battery life (Fenix lasts up to 37 days with solar; Epix Pro lasts up to 16 days), size options (Epix Pro comes in 42mm, 47mm, and 51mm; Fenix 7X Pro is 51mm only), and solar charging (Fenix has it; Epix Pro does not). Both retail at $999.99.

How long does the Garmin Epix Pro Gen 2 battery last?
Battery life varies by case size and usage. The 47mm model lasts up to 16 days in smartwatch mode and approximately 42 hours in GPS mode. The 51mm model lasts up to 21 days in smartwatch mode and approximately 57 hours in GPS mode. Using the always on AMOLED display reduces battery life significantly. All features are included with the $999.99 purchase price with no subscription required.

Is the Garmin Epix Pro Gen 2 good for sleep tracking?
The Epix Pro Gen 2 tracks sleep stages (light, deep, REM), provides a sleep score, monitors SpO2 overnight, and records HRV during sleep for its HRV Status feature. The 42mm and 47mm case sizes are more comfortable for overnight wear than larger watches. However, dedicated sleep trackers like the Oura Ring offer a more comfortable form factor and more detailed sleep analysis. The Epix Pro is best viewed as a training watch that also tracks sleep, not a sleep tracker that also tracks training.

Can the Garmin Epix Pro Gen 2 detect sleep apnea?
No. The Epix Pro Gen 2 does not have FDA clearance for sleep apnea detection. It does track SpO2 during sleep, which can reveal patterns of oxygen desaturation associated with sleep disordered breathing. However, it does not generate a clinical screening assessment. For FDA authorized sleep apnea screening on a smartwatch, the Samsung Galaxy Watch Ultra is currently the primary consumer option.

Does the Garmin Epix Pro Gen 2 work with iPhone?
Yes. The Epix Pro Gen 2 is fully compatible with both iOS and Android via the Garmin Connect app. All features, including ECG recording, HRV tracking, VO2 max estimation, training analytics, and map navigation, function identically on both platforms. This cross platform compatibility is a notable advantage over the Samsung Galaxy Watch Ultra and Apple Watch, which are restricted to their respective smartphone ecosystems.

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

Subscribe Free

No spam. Unsubscribe anytime. We respect your inbox.